Cls Holdings Usa Stock Fundamentals

CLSH Stock  USD 0.04  0  4.44%   
CLS Holdings USA fundamentals help investors to digest information that contributes to CLS Holdings' financial success or failures. It also enables traders to predict the movement of CLS OTC Stock. The fundamental analysis module provides a way to measure CLS Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CLS Holdings otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CLS Holdings USA OTC Stock Operating Margin Analysis

CLS Holdings' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current CLS Holdings Operating Margin

    
  (0.05) %  
Most of CLS Holdings' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CLS Holdings USA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, CLS Holdings USA has an Operating Margin of -0.0511%. This is 99.85% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 99.07% lower than that of the firm.

CLS Holdings USA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CLS Holdings's current stock value. Our valuation model uses many indicators to compare CLS Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CLS Holdings competition to find correlations between indicators driving CLS Holdings's intrinsic value. More Info.
CLS Holdings USA is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value CLS Holdings by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CLS Holdings' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

CLS Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CLS Holdings' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of CLS Holdings could also be used in its relative valuation, which is a method of valuing CLS Holdings by comparing valuation metrics of similar companies.
CLS Holdings is currently under evaluation in operating margin category among its peers.

CLS Fundamentals

About CLS Holdings Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CLS Holdings USA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CLS Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CLS Holdings USA based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. CLS Holdings USA, Inc. was founded in 2014 and is based in Miami, Florida. Cls Holdings operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.

Currently Active Assets on Macroaxis

Other Information on Investing in CLS OTC Stock

CLS Holdings financial ratios help investors to determine whether CLS OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CLS with respect to the benefits of owning CLS Holdings security.